WHO ICTRP trial
Quantitative assessment of TCR repertoire after standardized treatment in…
ChiCTR-OPC-15006506 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-OPC-15006506 |
|---|---|
| Public title | Quantitative assessment of TCR repertoire after standardized treatment in Graves' disease and Graves Ophthalmopathy |
| Scientific title | Quantitative assessment of TCR repertoire after standardized treatment in Graves' disease and Graves Ophthalmopathy |
| Primary sponsor | First Affiliated Hospital of Xi'an Jiaotong University Health Science Center |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Pilot study |
| Countries | China |
| Conditions | Graves’ disease and Graves Ophthalmopathy |
| Interventions | 1:Antithyroid drugs;2:methylprednisolone pulse therapy |
| Registration date | May 28, 2015 |
| Target size | 1:10;2:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: